These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38506052)

  • 1. Girls with idiopathic central precocious puberty did not display substatial changes in body mass index after treatment with gonadotropin-releasing hormone analogues.
    Uldbjerg CS; Lim YH; Renault CH; Hansen D; Juul A; Bräuner EV; Jensen RB
    Acta Paediatr; 2024 Jul; 113(7):1602-1611. PubMed ID: 38506052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of GnRH agonist treatment on body mass index in girls with idiopathic central precocious puberty.
    Vuralli D; Ozon ZA; Gonc EN; Alikasifoglu A; Kandemir N
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):99-105. PubMed ID: 31804960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN; Liang L; Cai XD; Li Z; Bai M; Gu CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P; Dejkhamron P; Wejaphikul K; Unachak K
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1369-1375. PubMed ID: 31605579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of BMI on long-term anthropometric and metabolic outcomes in girls with idiopathic central precocious puberty treated with GnRHas.
    Bruzzi P; Valeri L; Sandoni M; Madeo SF; Predieri B; Lucaccioni L; Iughetti L
    Front Endocrinol (Lausanne); 2022; 13():1006680. PubMed ID: 36263328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P; Suphasit R; Mahachoklertwattana P
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Body Mass Index in Girls with Idiopathic Central Precocious Puberty under Gonadotropin-Releasing Hormone Analogue Therapy: The Spanish Registry.
    Corripio R; Soriano-Guillén L; Herrero FJ; Cañete R; Castro-Feijoó L; Escribano A; Espino R; Labarta JI; Argente J
    Horm Res Paediatr; 2016; 86(3):154-160. PubMed ID: 27529349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychological behavior of girls with idiopathic central precocious puberty before and after treatment with gonadotropin-releasing hormone analogue].
    Zheng F; Zhu H; Jiang YJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 May; 37(3):289-94. PubMed ID: 18546533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life.
    Loochi SA; Demol S; Nagelberg N; Lebenthal Y; Phillip M; Yackobovitch-Gavan M
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):373-383. PubMed ID: 33609438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
    Vurallı D; Alikaşifoğlu A; İyigün İ; Canoruç D; Ozon A; Gönç N; Kandemir N
    J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):37-44. PubMed ID: 31347350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty.
    Arcari AJ; Freire AV; Escobar ME; Ballerini MG; Ropelato MG; Bergadá I; Gryngarten MG
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):181-186. PubMed ID: 30699070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty.
    Mondkar S; Khadilkar V; Yewale S; Dange N; More C; Khadilkar A
    J Pediatr Endocrinol Metab; 2024 Jan; 37(1):62-68. PubMed ID: 38008794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in body mass index in children on gonadotropin-releasing hormone agonist therapy with precocious puberty, early puberty or short stature.
    Censani M; Feuer A; Orton S; Askin G; Vogiatzi M
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1065-1070. PubMed ID: 31465296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the resilience of the girls with central precocious puberty treated with gonadotropin-releasing hormone analog.
    Odabasi Gunes S; Akin O; Eray S
    J Pediatr Endocrinol Metab; 2021 Nov; 34(11):1379-1384. PubMed ID: 34313086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index evolution and ovarian function in adolescent girls who received GnRH agonist treatment for central precocious puberty or early and fast puberty.
    Buyukyilmaz G; Koca SB; Adiguzel KT; Gurbuz F; Boyraz M
    J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1044-1051. PubMed ID: 37735929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent relationship between body mass index and LH peak value of GnRH stimulation test in ICPP girls: A cross-sectional study.
    Zhao Y; Hou L; Gao HJ; Zhan D; Zhang C; Luo XP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):556-562. PubMed ID: 28786058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final adult height in children with central precocious puberty - a retrospective study.
    Knific T; Lazarevič M; Žibert J; Obolnar N; Aleksovska N; Šuput Omladič J; Battelino T; Avbelj Stefanija M
    Front Endocrinol (Lausanne); 2022; 13():1008474. PubMed ID: 36531464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
    Lee HS; Yoon JS; Roh JK; Hwang JS
    Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.